Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NBIX | Common Stock | Options Exercise | $100K | +2.78K | +0.55% | $35.99 | 510K | Feb 13, 2024 | Direct | F1 |
transaction | NBIX | Common Stock | Options Exercise | $100K | +2.31K | +0.45% | $43.24 | 512K | Feb 13, 2024 | Direct | F1, F2 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | NBIX | Incentive Stock Option | Options Exercise | -$100K | -2.78K | -100% | $35.99 | 0 | Feb 13, 2024 | Common Stock | 2.78K | $35.99 | Direct | F3 |
transaction | NBIX | Incentive Stock Option | Options Exercise | -$100K | -2.31K | -100% | $43.24 | 0 | Feb 13, 2024 | Common Stock | 2.31K | $43.24 | Direct | F4 |
Id | Content |
---|---|
F1 | This transaction involved a cash exercise of a stock option without a subsequent sale of the underlying shares of common stock. |
F2 | 491,365 of the outstanding shares are held by the Gorman and Blais Family Trust, of which Dr. Gorman has voting and investment power. |
F3 | The option was granted February 5, 2016 and vested in 48 equal monthly installments beginning March 5, 2016. |
F4 | The option was granted February 6, 2017 and vested in 48 equal monthly installments beginning March 6, 2017. |